Birgit Schultes's most recent trade in Intellia Therapeutics Inc was a trade of 8,508 Common Stock done at an average price of $9.2 . Disclosure was reported to the exchange on Jan. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | Birgit Schultes | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.21 per share. | 05 Jan 2026 | 8,508 | 98,533 (0%) | 0% | 9.2 | 78,359 | Common Stock |
| Intellia Therapeutics Inc | Birgit Schultes | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.39 per share. | 01 Oct 2025 | 31 | 105,184 (0%) | 0% | 17.4 | 539 | Common Stock |
| Intellia Therapeutics Inc | Birgit Schultes | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 53,714 | 53,714 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Birgit Schultes | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 37,600 | 105,215 (0%) | 0% | 0 | Common Stock |